Surgery Partners, Inc.: shareholders and insiders

SGRYNASDAQHealthcare · Services-General Medical & Surgical Hospitals, NEC

Price

$26.96

November 18, 2026Market cap $3.5B

What Ploutos Investor adds for Surgery Partners

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 12 fiscal years, from 2013
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Aug 19, 2026, from their own Form 4 filings.

9 Form 4s

Bought on the market

$143.5K

1 person

Sold on the market

$1.3M

6 people

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $304.7K by 1 person·sold $1.3M by 6 people

  • 2025: no buys, no sales
  • 2026: bought $304.7K by 1 person, sold $1.3M by 6 people
  • Aug 18, 2026Teresa DeLucaDirector
    Kind
  • Jun 18, 2026Blair E HendrixDirector
    Kind
  • Jun 5, 2026Blair E HendrixDirector
    Kind
  • Jun 5, 2026John A DeaneDirector
    Kind
  • Jun 5, 2026Laura L ForeseDirector
    Kind
  • Jun 5, 2026Clifford G AdlerzDirector
    Kind
  • Jun 5, 2026Lloyd H DeanDirector
    Kind
  • Jun 5, 2026Teresa DeLucaDirector
    Kind
  • Jun 5, 2026Brent TurnerDirector
    Kind
  • Mar 16, 2026Jason Eric EvansChief Executive Officer
    Kind
  • Mar 16, 2026David T DohertyChief Financial Officer
    Kind
  • Mar 13, 2026Marissa BrittenhamChief Strategy Officer
    Kind
  • Mar 13, 2026Danielle BurkhalterChief Human Resources Officer
    Kind
  • Mar 12, 2026Jennifer BaldockChief Admin & Dev Officer
    Kind
  • Mar 6, 2026Marissa BrittenhamChief Strategy Officer
    Kind
  • Mar 6, 2026William Trenton WebbAmerican Group President
    Kind
  • Mar 6, 2026Danielle BurkhalterChief Human Resources Officer
    Kind
  • Mar 6, 2026Jennifer BaldockChief Admin & Dev Officer
    Kind
  • Mar 6, 2026David T DohertyChief Financial Officer
    Kind
  • Mar 6, 2026Jason Eric EvansChief Executive Officer
    Kind
  • Mar 5, 2026William Trenton WebbAmerican Group President
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 9, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by SGRY's officers and directors from 2015 up to November 18, 2025, 11 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%1 On a 13DNov 6, 2026 Latest filing
  • BCPE Seminole Holdings LPwith 3 more persons
    Share of class23.0%
  • Pentwater Capital Management LPwith 1 more person
    Share of class9.70%
  • Glenview Capital Managementwith 1 more person
    Share of class5.40%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • BCPE Seminole Holdings LP23.0%From the filing of Oct 26, 2026

    Item 4 of the Initial Statement is hereby amended and supplemented by adding the following at the end of Item 4 of the Initial Statement: As disclosed by the Issuer in its Current Report on Form 8-K, filed with the Securities and Exchange Commission on October 26, 2026, on October 23, 2026 the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Spyglass Topco, LLC, a Delaware limited liability company ("Parent"), Spyglass Merger Subsidiary, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Subsidiary"), and, solely for the limited purposes set forth therein, Bon Secours Mercy Health, Inc., a Maryland nonstock, nonprofit corporation…

    From the filing of Oct 26, 2026
Fell to 5% or less (6)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • JANUS HENDERSON GROUP Ltd.4.90%Nov 6, 202613G/A
  • King Street Capital Management, L.P.4.60%Aug 14, 202613G
  • FMR1.70%May 6, 202613G/A
  • The Vanguard Group0.00%Mar 27, 202613G/A
  • Wellington Management Group LLP0.00%Aug 12, 202513G/A
  • BlackRock, Inc.4.40%Apr 29, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Glenview Capital
    In the quarter
  • Oaktree (Marks)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+89%
  • Renaissance Technologies
    In the quarter
  • AQR Capital
    In the quarter+730%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 11.1% of its shares outstanding were held short, -0.1% since the report before.

Shares held short
14.33M
11.1%
Since the report before14.35M on Sep 30, 2026
-0.1%
10.3
1.39M
More days to cover thanof 4,578 US-listed companies with enough volume
92%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 7.45M
  • Nov 15, 2023: Shares held short 7.82M
  • Nov 30, 2023: Shares held short 6.44M
  • Dec 15, 2023: Shares held short 7.13M
  • Dec 29, 2023: Shares held short 6.54M
  • Jan 12, 2024: Shares held short 7.11M
  • Jan 31, 2024: Shares held short 7.78M
  • Feb 15, 2024: Shares held short 7.19M
  • Feb 29, 2024: Shares held short 7.76M
  • Mar 15, 2024: Shares held short 8.04M
  • Mar 28, 2024: Shares held short 8.27M
  • Apr 15, 2024: Shares held short 8.60M
  • Apr 30, 2024: Shares held short 8.94M
  • May 15, 2024: Shares held short 9.71M
  • May 31, 2024: Shares held short 10.87M
  • Jun 14, 2024: Shares held short 11.11M
  • Jun 28, 2024: Shares held short 11.81M
  • Jul 15, 2024: Shares held short 12.27M
  • Jul 31, 2024: Shares held short 10.95M
  • Aug 15, 2024: Shares held short 11.32M
  • Aug 30, 2024: Shares held short 10.83M
  • Sep 13, 2024: Shares held short 9.98M
  • Sep 30, 2024: Shares held short 10.10M
  • Oct 15, 2024: Shares held short 10.12M
  • Oct 31, 2024: Shares held short 10.16M
  • Nov 15, 2024: Shares held short 10.07M
  • Nov 29, 2024: Shares held short 11.19M
  • Dec 13, 2024: Shares held short 10.89M
  • Dec 31, 2024: Shares held short 11.01M
  • Jan 15, 2025: Shares held short 10.56M
  • Jan 31, 2025: Shares held short 9.45M
  • Feb 14, 2025: Shares held short 10.25M
  • Feb 28, 2025: Shares held short 9.98M
  • Mar 14, 2025: Shares held short 10.18M
  • Mar 31, 2025: Shares held short 10.19M
  • Apr 15, 2025: Shares held short 9.51M
  • Apr 30, 2025: Shares held short 9.54M
  • May 15, 2025: Shares held short 9.56M
  • May 30, 2025: Shares held short 9.36M
  • Jun 13, 2025: Shares held short 9.41M
  • Jun 30, 2025: Shares held short 11.43M
  • Jul 15, 2025: Shares held short 11.85M
  • Jul 31, 2025: Shares held short 12.83M
  • Aug 15, 2025: Shares held short 12.75M
  • Aug 29, 2025: Shares held short 12.69M
  • Sep 15, 2025: Shares held short 13.22M
  • Sep 30, 2025: Shares held short 12.28M
  • Oct 15, 2025: Shares held short 14.18M
  • Oct 31, 2025: Shares held short 13.66M
  • Nov 14, 2025: Shares held short 14.21M
  • Nov 28, 2025: Shares held short 14.20M
  • Dec 15, 2025: Shares held short 14.48M
  • Dec 31, 2025: Shares held short 15.84M
  • Jan 15, 2026: Shares held short 15.54M
  • Jan 30, 2026: Shares held short 17.73M
  • Feb 13, 2026: Shares held short 16.39M
  • Feb 27, 2026: Shares held short 13.81M
  • Mar 13, 2026: Shares held short 13.42M
  • Mar 31, 2026: Shares held short 14.00M
  • Apr 15, 2026: Shares held short 15.84M
  • Apr 30, 2026: Shares held short 15.81M
  • May 15, 2026: Shares held short 14.49M
  • May 29, 2026: Shares held short 13.72M
  • Jun 15, 2026: Shares held short 14.27M
  • Jun 30, 2026: Shares held short 15.13M
  • Jul 15, 2026: Shares held short 14.80M
  • Jul 31, 2026: Shares held short 13.54M
  • Aug 14, 2026: Shares held short 12.65M
  • Aug 31, 2026: Shares held short 12.95M
  • Sep 15, 2026: Shares held short 13.29M
  • Sep 30, 2026: Shares held short 14.35M
  • Oct 15, 2026: Shares held short 14.33M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading38.8% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 38.8% of the shares in the reported trades were short sales, against 23.8% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
38.8%
The 14 beforeOct 12, 2026 – Oct 29, 2026
23.8%
Change
+15.0 pts
Short sales a dayon average, of 2.30M shares
893.2K
More than atof 3,656 US-listed companies, same days
17%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 64%
  • Oct 13, 2026: Short sales 65.1%
  • Oct 14, 2026: Short sales 51.7%
  • Oct 15, 2026: Short sales 29.6%
  • Oct 16, 2026: Short sales 79.5%
  • Oct 19, 2026: Short sales 61.9%
  • Oct 20, 2026: Short sales 22.2%
  • Oct 21, 2026: Short sales 29.1%
  • Oct 22, 2026: Short sales 31.1%
  • Oct 23, 2026: Short sales 38.2%
  • Oct 26, 2026: Short sales 19.9%
  • Oct 27, 2026: Short sales 32.8%
  • Oct 28, 2026: Short sales 21.2%
  • Oct 29, 2026: Short sales 12.8%
  • Oct 30, 2026: Short sales 46.5%
  • Nov 2, 2026: Short sales 47.5%
  • Nov 3, 2026: Short sales 18%
  • Nov 4, 2026: Short sales 59.2%
  • Nov 5, 2026: Short sales 15.7%
  • Nov 6, 2026: Short sales 20.5%
  • Nov 9, 2026: Short sales 27.5%
  • Nov 10, 2026: Short sales 52.5%
  • Nov 11, 2026: Short sales 20.3%
  • Nov 12, 2026: Short sales 52.8%
  • Nov 13, 2026: Short sales 34%
  • Nov 16, 2026: Short sales 38.4%
  • Nov 17, 2026: Short sales 48.1%
  • Nov 18, 2026: Short sales 33.4%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

154M Insiders' shares118.82% Of the company
  • BCPE Seminole Holdings II Intermediate LPDirector,TenPercentOwner
    Directly–
  • T. Devin O'ReillyDirector,TenPercentOwner
    Directly–
  • Andrew T. KaplanDirector,TenPercentOwner
    Directly–
  • Jason Eric EvansChief Executive Officer
    Directly920.4K
  • Jennifer BaldockChief Admin & Dev Officer
    Directly326.5K
  • David T DohertyChief Financial Officer
    Directly221.7K
  • Wayne S DeVeydtExec Chairman of the Board
    Directly131.9K
  • Harrison R. BaneNational Group President
    Directly117.2K
  • Anthony TaparoChief Growth Officer
    Directly102.3K
  • Marissa BrittenhamChief Strategy Officer
    Directly94.2K
  • Brent TurnerDirector
    Directly86.6K
  • Danielle BurkhalterChief Human Resources Officer
    Directly76.9K
  • William Trenton WebbAmerican Group President
    Directly74.2K
  • Bradley R. OwensNational Group President
    Directly72.3K
  • Clifford G AdlerzDirector
    Directly69.1K
  • Teresa DeLucaDirector
    Directly68.1K
  • Blair E HendrixDirector,TenPercentOwner
    Directly52.9K
  • John A DeaneDirector
    Directly45.9K
  • Patricia Anne MarylandDirector
    Directly24.6K
  • Laura L ForeseDirector
    Directly18.5K
  • Lloyd H DeanDirector
    Directly11.7K

A lower bound: it counts only the 21 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

20 ETFs holding it0.20% The largest weight (IHF)
  • IHFiShares U.S. Healthcare Providers ETF
    Weight in the fund0.20%
  • DFSVDimensional US Small Cap Value ETF
    Weight in the fund0.11%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.09%
  • FNDASchwab Fundamental U.S. Small Company ETF
    Weight in the fund0.06%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.04%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.04%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.03%
  • VBRVanguard Small-Cap Value Index Fund
    Weight in the fund0.03%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.02%
  • VBVanguard Small-Cap Index Fund
    Weight in the fund0.02%

20 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

187 Managers, Q2 2026$2.6B Value of their positions
  • Q3 2025: Managers 201
  • Q4 2025: Managers 181
  • Q1 2026: Managers 184
  • Q2 2026: Managers 187

Institutional investors by quarter

The fund managers holding SGRY, quarter by quarter, from Q4 2015 to Q2 2025, 39 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 187 managers held 158M shares, worth $2.6B. During the quarter 35 opened a position, 32 closed one, 69 added and 50 trimmed.

The largest holders, Q2 2026

  • Bain Capital Investors
    In the quarter
  • Jupiter Topco
    In the quarter
  • Pentwater Capital Management
    In the quarter-8.1%
  • UBS Group
    In the quarter-16%
  • BlackRock
    In the quarter+10%
  • King Street Capital Management
    In the quarter-41%
  • T. Rowe Price Investment Management
    In the quarter+203%
  • Dimensional Fund Advisors
    In the quarter-6.7%
  • Clearbridge Investments
    In the quarter-7.2%
  • Vanguard Portfolio Management
    In the quarter+3.0%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Surgery Partners's filings show?

Who buys and sells is one part of Surgery Partners's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SGRY's shareholders

Didn't find what you were looking for?

Ask us
Have SGRY's insiders bought or sold?

From Jun 9, 2026 to Aug 19, 2026 Surgery Partners's insiders bought $143.5K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Which well-known managers hold SGRY?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was Glenview Capital's, worth $90M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.